KM Laurence. Hydrocephalus and Malformations of the Central Nervous System. In Jean W. Keeling (Ed). Fetal and Neonatal Pathology. Second edition. Springer-Verlag 1993, pp 541-570

Khoury MJ, Beaty TH, Cohen BH: Genetic Epidemiology in Medicine and Public Health, Chapter 10. Oxford University Press 1993, pp316-317

Milunsky A: Maternal Serum Screening for Neural Tube Defects. In Genetic Disorders and the Fetus, third edition. Johns HopkinsUniversity Press 1992, pp507-511

Laurence KM: Genetics and Prevention of Neural Tube Defects and Uncomplicated Hydrocephalus. In: Emery AEH, Rimoin DI (eds) Principles and Practice of Medical Genetics, 2nd. Edition, Churchill Livingstone 1990, pp 323-346

Tolmie J: Neural Tube Defects and other congenital Malformations of the Central Nervous System. In: Emery AEH, Rimoin DI (Eds) Principles and Practice of Medical Genetics, 3rd. Edition, Churchill Livingstone 1997, pp 2151

Mulinare J, Cordero JF, Erickson JD, Berry RJ: Periconceptional use of vitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-3145

Centers for Disease Control and Prevention: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR;1992:41(no.RR-14):1-7

Centers for Disease Control and Prevention: Use of folic acid for prevention of spina bifida and other neural tube defects. MMWR;1991:40:513-516

[9] Hibbard BM: The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion. J Obstet Gynecol Br Commonw 1964;71:529

Smithells RW, Sheppard S, Schorah CJ: Vitamin deficiencies and neural-tube defects. Arch Dis Child 1976;51:944

Laurence KM: The effect of early surgery for spina bifida cystica on survival and quality of life. Lancet 1974 ; I:301-304

Laurence KW: prenatal detection and prevention of neural tube defects in South Wales. J Soc Health 1986; 106:153-160

Lawrence KW: The declining incidence of neural tube defects in the UK. Z Kinderchir 1989;41:51

Lawrence KW, Tew BJ: The natural history of spina bifida cystica and cranium bifidum cysticum: the central nervous system malformations in South Wales Part IV. Arch Dis Child 1971;467:127-138

Milunsky A, Alpert E. Results and benefits of maternal serum alpha-fetoprotein screening program. JAMA 1984;252:1438.

Brock DJH, Bolton AE, Monaghan JM. Prenatal diagnosis of anencephaly trough maternal serum alpha-fetoprotein measurement. Lancet 1973;2:923.

Holmes LB, Driscoll S, Atkins L: Etiologic heterogeneity of neural tube defects. N Engl J Med 1976;294:365-369

Khoury MJ, Erickson JD, James LM: Etiologic heterogeneity of neural tube defects: Clues from epidemiology. Am J Epidemiol 1982a;115:538-548.

Bower C, Stanley FJ: Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619.

Mills JL, Rhoads GG, Simpson JL, et al.: The absence of relation between the periconceptional use of vitamins and neural-tube defects. N Eng J Med 1989;321:430-435.

Milunsky A, Jick H, Jik SS, et al.: Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852.

Vergel RG, Sanchez LR, Heredero BL, et al.: Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:1027-1031.

Werler, Shapiro S, Mitchell AA: Periconceptional folic acid exposure and risk of occurrence neural tube defects. JAMA 1993;269:1257-1261.

Shaw GM, Schaffer D, Velie EM, et al.: Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California. Epidemiology 1995;6:219-226.

MRC Vitamin Study Research Group: Prevention of neural tube defects results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-137.

Czeizel AE, Dudas I: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 1992;327:1832-1835.

Werler MM, Louik C, Shapiro S, Mitchell AA: Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089-1092.

Cuskelly GJ, McNulty H, Scott JM: Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-659.

Institute of Medicine: Dietary Reference Intakes for Thiamine, Rivoflavine, Niacine, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotine and Choline. National Academy Press, Washington, D.C., 1998; 8-26/36.

Food and Drug Administration: Food Standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996;8781-8797.

Centers for Disease Control and Prevention: Knowledge and use of folic acid by women of childbearing age – United States. MMWR;1997:46:721-23.

Congenital Malformations Worldwide: A report from The International Clearinghouse for Birth Defects Monitoring Systems . International Centre for Birth Defects, Italy. 1997.

Hook EB, Czeizel AE: can terathanasia explain the protective effect of folic acid supplements on birth defects? Lancet 1997;350:513-515.

Centers for Disease Control and Prevention: Use of folic acid-containing supplements among women of childbearing age-United States. MMWR;1998:47:131-134

National Birth Defect Prevention Network. Congenital Malformations Surveillance Report. Teratology 1997; 56(1/2):116 – 175

International Clearinghouse for Birth Defects Monitoring Systems (1991): “Congenital malformations Worldwide: A Report from the International Clearinghouse for Birth Defects Monitoring Systems.” Amsterdam: Elsevier Science Publishers.

Olney R, Mulinare J. Epidemiology of Neural Tube Defects, in press

Clinical Genetics Handbook pg. 63

Elwood JM, Little J, Elwood JH (1992): “Epidemiology and Control of Neural Tube Defects.” New York: Oxford University Press.

Centers for Disease Control and Prevention: Prevalence of spina bifida at birth – United States, 1983-1990: a comparison of two surveillance systems. MMWR 1998;45 (No. SS-2):15-26.

Baird PA. Neural tube defects in the Sikhs. Am J Med Genet 1983;16:49-56.

Elwood JH. Major central nervous system malformations notified in Northern Ireland 1964-1968. Dev Med Child Neurol 1972;14:731-9.

Isaza C, Martina D, Estupinan J, Starck C, Rey H: Prevalencia de malformaciones congenitas diagnosticadas en las primeras 24 horas. Colombia Medica vol 1989;20 (4)

Mckusick VA. Mendelian Inheritance in Man 11th Edition. Johns Hopkins Press, 1994.

Sever LE. Epidemiological aspects of neural tube defects. In: Crandall BF and Brazier MAB (eds): “Prevention of Neural Tube Defects.” London: Academic Press, 1978, pp 75-89.

Bound JP, Harvey PW, Francis BJ, Awwad F, Gatrell AC. Involvement of deprivation and environmental lead in neural tube defects: a matched case-control study. Arch Dis Child 1997;76:107-112.

Lynberg MC, Khoury MJ, Lu X, Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidem 1994;140(3): 244-255.

Milunsky A, Ulcickas M, Rothman, et al. Maternal heat exposure and neural tube defects. JAMA 1992;268;882-5.

Blatter BM, Roeleveld N, Zielhuis GA, Mullaart RA, Gabreels FJM. Spina bifida and parental occupation. Epidemiol 1996; 7(2):188-193.

Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect – affected pregnancies among obese women. JAMA 1996;275(14):1093-1096.

Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-137.

Wills L, Mehta MM. Studies in “pernicious anemia” of pregnancy. Part I. Preliminary report. Ind J Med Res 1930;17:777-792.

Herbert VD, Colamn N, Folic Acid and vitamin B12. In Shils ME, Young VR (eds): “Modern Nutrition in Health and Disease.” 7th ed. Philadelphia: Lea & Febiger, p 388-416.

Locksmith GJ, Duff P. Preventing neural tube defects: The importance of periconceptional folic acid supplements. Obstetr & Gynecol 1998;91(6):1027-1034.

Shaw GM, Lammer EJ, Wasserman CR, O’Malley CD, Tolarova MM: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995;346:393-396.

Tolarova M, Harris J: Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995;51:71-18.

Hayes C, Werler MM, Willett WC, Mitchell AA: Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 1996;143:1229-1234.

Yang Q, Khoury MJ, Olney RS, Mulinare J: Does periconceptional multivitamine use reduce the risk for limb deficiency in offspring? Epidemiology 1997;8:157-161.

Botto LD, Khoury MJ, Mulinare J, Ericson JD: Periconceptional multivitamin use and the occurrence conotruncal heart defects: results from a population based case-control study. Pediatrics 1996;98:911-917.

Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS: Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995;6:205-207.

Romano PS, Waitzman NJ, Scheffler RM, Pi RD. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995;85:667-676.

Cragan JD, Roberts HE, Edmonds LD et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis- united States, 1985-1994. MMWR CDC Surveill Summ 1995;44: No. SS-4.

Eassien FB, Wannenberg SL. Methionine but not folinic acid or vitamine B12 alters the frequency of neural tube defects in Axd mutant mice. J Nutr 1993;123:27-34.

Coelho CND, Klein NW: Methionine and neural tube closure in cultured rat embryos: Morphological and biochemical analyses. Teratology 1990;42:437-451.

Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc Natl Acad Sci USA 1996;93:15227-32.

Kirke PN, Mills JL, Whitehead AS, Molloy A, Scout JM. Methylentetrahydrofolate reductase mutation and neural tube defects. Lancet 1996;348:1037-1038.

Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: An inheritedrisk factor for coronary artery disease. Am J Hum Genet 1991;48:536-545.

Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al.: Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low red-cell folates:Implications for folate intake recommendations. Lancet 1997;349:1591-1593.

Kang SS, Zhou J, Wonk PKW, Kowalisyn J, Sttrokosch G: Intermediate hyperhomocystinemia: Athermolabile defect of methylenetetrahydrofolate reductase. Am J Hum Genet 1988;43:414-421.

Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, et al.: A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995;88:763-766.

Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van der Heuvel LP, et al.: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.

Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, et al.: 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996;63:610-614.

Toriello HV, Higgins JV: Occurrence of neural-tube defects among first-, second and third degree relatives of probands: Results of a United States study. Am J Med Genet 1983;15:601.

Smithells RW, Sheppard S, Schorah CJ, et al.: Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-40